These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38937742)

  • 21. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
    Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
    J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway.
    Yang M; Zhang H; Gao S; Huang W
    J Orthop Surg Res; 2023 Feb; 18(1):145. PubMed ID: 36849972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
    Feng F; Zhao Z; Cai X; Heng X; Ma X
    Cancer Med; 2023 Mar; 12(5):5889-5907. PubMed ID: 36284444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel KIF4A-Related Model for Predicting Immunotherapy Response and Prognosis in Kidney Renal Clear Cell Carcinoma.
    Yang GH; Ma XD; Wei XF; Liu RL; Wang C
    Comb Chem High Throughput Screen; 2024 Feb; ():. PubMed ID: 38357945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KIF4A knockdown inhibits tumor progression and promotes chemo-sensitivity via induction of P21 in lung cancer cells.
    Zhang D; Lu W; Samadi N
    Chem Biol Drug Des; 2023 May; 101(5):1042-1047. PubMed ID: 36217900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced expression of KIF4A in osteosarcoma predicts a poor prognosis and facilitates tumor growth by activation of the MAPK pathway.
    Zhu D; Xu X; Zhang M; Wang T
    Exp Ther Med; 2021 Nov; 22(5):1339. PubMed ID: 34630693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of HOXC10 gene on biological behaviors of glioma cells and mechanism in tumor microenvironment].
    Jiang WY; Lei QY; Liu SS; Yang L; Yang B; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):228-237. PubMed ID: 35316872
    [No Abstract]   [Full Text] [Related]  

  • 28. GRB10 is a novel oncogene associated with cell proliferation and prognosis in glioma.
    Chen Y; Tang M; Xiong J; Gao Q; Cao W; Huang J
    Cancer Cell Int; 2022 Jul; 22(1):223. PubMed ID: 35790975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-137 inhibits the proliferation, invasion and migration of glioma via targeting to regulate EZH2.
    Gu J; Wang J; You A; Li J; Zhang Y; Rao G; Ge X; Zhang K; Liu X; Wang D
    Genes Genomics; 2021 Oct; 43(10):1157-1165. PubMed ID: 34160745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PODNL1 promotes cell proliferation and migration in glioma via regulating Akt/mTOR pathway.
    Geng Y; Zuo P; Li XO; Zhang L
    J Cancer; 2020; 11(21):6234-6242. PubMed ID: 33033506
    [No Abstract]   [Full Text] [Related]  

  • 31. KIF4A as a novel prognostic biomarker in cholangiocarcinoma.
    Zhang DY; Ma SS; Sun WL; Lv XCH; Lu Z
    Medicine (Baltimore); 2021 May; 100(21):e26130. PubMed ID: 34032761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-182 promotes glioma progression by targeting FBXW7.
    Liu S; Liu H; Deng M; Wang H
    J Neurol Sci; 2020 Apr; 411():116689. PubMed ID: 32032908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TROAP regulates cell cycle and promotes tumor progression through Wnt/β-Catenin signaling pathway in glioma cells.
    Zhao ZQ; Wu XJ; Cheng YH; Zhou YF; Ma XM; Zhang J; Heng XY; Feng F
    CNS Neurosci Ther; 2021 Jun; 27(9):1064-76. PubMed ID: 34077623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of COL6A2 in malignant progression and temozolomide resistance of glioma.
    Hong X; Zhang J; Zou J; Ouyang J; Xiao B; Wang P; Peng X
    Cell Signal; 2023 Feb; 102():110560. PubMed ID: 36521657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value.
    Zhou Y; Yang L; Zhang X; Chen R; Chen X; Tang W; Zhang M
    Biomed Res Int; 2019; 2019():6581576. PubMed ID: 31119182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin Exerts Its Antitumor Effect in Esophageal Squamous Cell Carcinoma by Downregulating the Expression of ATAD2 and KIF4A.
    Zhang M; Ren Z; Wang X; Liu C; Zheng Z; Zhao J; Liu H
    Anal Cell Pathol (Amst); 2022; 2022():7005328. PubMed ID: 36046597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chalcone 9X Contributed to Repressing Glioma Cell Growth and Migration and Inducing Cell Apoptosis by Reducing FOXM1 Expression In Vitro and Repressing Tumor Growth In Vivo.
    Li C; Wang R; Guo W; Feng X; Guan N
    Biomed Res Int; 2022; 2022():8638085. PubMed ID: 35978634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EZH2 suppresses insulinoma development by epigenetically reducing KIF4A expression via H3K27me3 modification.
    Zhang S; Liu J; Li F; Yang M; Wang J
    Gene; 2022 May; 822():146317. PubMed ID: 35182680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients.
    Liu Z; Zhang W; Cheng X; Wang H; Bian L; Wang J; Han Z; Wang Y; Lian X; Liu B; Ren Z; Zhang B; Jiang Z; Lin Z; Gao Y
    Mol Med; 2021 May; 27(1):52. PubMed ID: 34051735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of KIF4A on Cancer Stem Cells and EMT in Lung Cancer and Glioma.
    Kahm YJ; Kim IG; Jung U; Lee JH; Kim RK
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.